中文 | English
Return
Total: 93 , 1/10
Show Home Prev Next End page: GO
MeSH:(Protein-Tyrosine Kinase/metabolism)

1.Significance of MEK-ERK cascade in the development of human breast carcinoma.

Shu WANG ; Shan WANG ; Xueguang ZHU ; Jiaqing ZHANG ; Xinmin QIAO ; Yingjiang YE ; Bin LIANG ; Xiangtao MA ; Zhirong CUI

Chinese Journal of Surgery 2002;40(3):171-174

2.WEE1, histone and tumor.

Bin LIU

Journal of Central South University(Medical Sciences) 2015;40(7):806-810

3.Advance of study on Mer function.

Lei FAN ; Chang-Geng RUAN

Journal of Experimental Hematology 2007;15(4):892-895

4.Effects of FMS-like tyrosine kinase 3 targeted RNA interference on proliferation and apoptosis of acute monocytic leukemia cell line THP-1.

Jie LU ; Guang-yao SHENG ; Xiang ZOU ; Xue-ju XU ; Xiao-ming ZHAO ; Song-ting BAI ; Pei-rong XU

Chinese Journal of Pediatrics 2007;45(8):615-619

6.Cross-linking of CD4 induces cytoskeletal association of CD4 and p56lck.

Young Mie HA-LEE ; Yoon Sil LEE ; Young Kee KIM ; Jeong Won SOHN

Experimental & Molecular Medicine 2000;32(1):18-22

7.Dynamic changes in focal adhesion kinase during cell migration induced by bFGF and the significance.

Guang-Bo LIANG ; Guo-Ping ZHANG ; Hui-Ming JIN ; Rui-Zhe QIAN

Acta Physiologica Sinica 2004;56(4):509-514

8.Time course degeneration and expression of glial fibrillary acidic protein in mer-knockout mice.

Xiao-Ying LIANG ; Huai-Zhou WANG ; Ning-Li WANG

Chinese Medical Journal 2010;123(7):949-953

9.Activation of PKCdelta by tyrosine phosphorylation in rat parotid acinar cells.

Cyril BENES ; Yue ZHENG ; Stephen P SOLTOFF

Journal of Korean Medical Science 2000;15(Suppl):S40-S41

10.Immunoreactivity of CD99 in Non-Hodgkin's Lymphoma: Unexpected Frequent Expression in ALK-positive Anaplastic Large Cell Lymphoma.

Chang Ohk SUNG ; Young H KO ; Sanghui PARK ; Kihyun KIM ; Wonseog KIM

Journal of Korean Medical Science 2005;20(6):952-956

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 93 , 1/10 Show Home Prev Next End page: GO